Seventy-four ethanolic extracts were prepared from traditionally used medicinal plants in the Jongilanga community in Mpumalanga South Africa. The aim was to determine the biological activity of the selected plants against cancer, mycobacteria species and acne. From the results, it was evident that Mundulea sericea was able to inhibit the proliferation of human melanoma cells (A375) with a fifty percent inhibitory concentration (IC50) ranging between 50 and 100 µg/ml as well as the ability to inhibit Mycobacterium tuberculosis, Mycobacterium smegmatis and Propionibacterium acnes with minimum inhibitory concentrations (MIC) of 125, 31.25 and 7.9 µg/ml respectively. This further led to the investigation of the antioxidant and anti-inflammatory activity as well as the influence of the extract on mycothiol disulphide reductase (Mtr) and glutathione reductase enzymes (Gtr) as potential targets against the above-mentioned diseases. M. sericea inhibited the COX-2 enzyme, responsible for inflammation, with an IC50 value of 10.70 ± 1.14 µg/ml, furthermore compounds previously isolated from M. sericea showed potential inhibition of COX-2 in molecular docking studies. Low radical scavenging capacity against the DPPH free radical with an IC50 value of 60.52 ± 2.40 µg/ml was obtained, however, M. sericea showed a higher affinity towards Mtr as compared to Gtr, which makes it an ideal plant for use as an antimycobacterial agent.
INTRODUCTION
Traditional medicine is still one of the primary sources of healthcare in South Africa, with an estimated 27 million individuals relying on traditional medicine. It has been reported that the primary use of traditional medicine is not primarily due to inaccessibility of Western medicine but is due to preference. The trade of traditional medicine results in approximately R2.9 billion, which equates to the usage of an estimated 20,000 tonnes of plant material per year. Most of the plants that are used are indigenous, with a variety of plant parts being used, including bark (27%), roots (27%), bulbs (14%), whole plant (13%), leaves and stems (10%), tubers (6%) and a mixture of parts (3%) 1 . The Cancer Association of South Africa (CANSA) has reported that there is an average lifetime risk of one in every nine females (1:8) and one in every eight males (1:7) to be diagnosed with cancer in South Africa. Furthermore, skin cancer in South Africa accounts for 20,000 new cases and 700 deaths and is the most common cancer in South Africa 2 . Furthermore, a study on dermatological disorders in Johannesburg in 2003 based on 1999 data showed that out of a sample size of 7029 people, acne was the second most prevalent skin disorder making up 16% of the surveyed population. A more recent study in KwazuluNatal showed that acne vulgaris makes up 10.3% of the surveyed patients, and other forms of acne account for 44.3% of the recorded diseases 3, 4 . Lastly, the WHO in 2013 identified South Africa as one of the countries with the highest rate of TB-infected individuals, with 450,000 new reported cases 5 . Stats SA recorded for the period between [2011] [2012] [2013] , that communicable diseases such as tuberculosis and pneumonia were the leading causes of death across the country with tuberculosis (TB, MDR-TB and XDR-TB) accounting for 8.8% thereof 6 . The selected plant species in this study were therefore, evaluated in vitro for activity against Mycobacterium smegmatis (non-pathogenic strain), Mycobacterium tuberculosis (pathogenic strain) and Propionibacterium acnes for anti-TB and anti-acne activity respectively. Anticancer activity was investigated against malignant melanoma (A375 cells). Further investigations were performed on Mundulea sericea where the highest activity against the above mentioned disorders was observed. Studies included anti-inflammatory activity using cyclooxygenase-2 (COX-2) enzyme, antioxidant activity against 2, 2-diphenyl-1-picrylhydrazyl radical (DPPH) and inhibitory activity against glutathione reductase and mycothiol disulfide reductase, enzymes responsible for maintaining oxidative stress in humans and M. tuberculosis respectively.
In this study, medicinal plants were selected from a database of plants and treatments practiced by traditional healer (TDr) James Mahore that falls under the Jongilanga tribal council, Bushbuckridge municipality, Mpumalanga province, South Africa. 
Plant collection
Plant material was collected from different villages within the Jongilanga community, Mpumalanga. Herbarium specimens were prepared and deposited into the HGWJ Schweickerdt Herbarium (Pru) of the University of Pretoria. Each plant species was provided with a specimen number ( Table 1) . Herbarium specimens were taxonomically identified at the HGWJ Schweickert Herbarium of the University of Pretoria and the South African National Biodiversity Institute.
Plant extraction
The plant material was shade dried for two weeks and then ground to a fine powder. The dried powder of each plant (20 g) was macerated in distilled ethanol (300 ml) and extracted for 48 h (twice) on a shaker. The plants were then filtered using a Buchner funnel with Whatman No.1 filter paper. The filtrate of each plant was collected and subjected to reduced pressure using a Büchi Rotavapor R-200. The extracts were kept in a cold room until further use. All plant names have been checked using The Plant List www.theplantlist.org Cell culture and cytotoxicity The human malignant melanoma (A375) cell line was maintained in culture flasks containing Dulbecco's Modified Eagles Medium (DMEM). The cells were supplemented with 1% antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin and 250 µg/l fungizone) and 10% heat-inactivated fetal bovine serum. The cells were grown at 37°C and 5% CO2 and sub-cultured after cells formed an 80% confluent monolayer. Cytotoxicity was measured using the 2, 3-Bis-(2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxyanilide salt (XTT) method. The method described by Berrington and Lall was used 8 . One hundred microliters of cells were seeded in 96-well plates at 1×10 5 cells/ml and incubated for 24 h at 37ºC and 5% CO2 for cells to adhere. The extracts were prepared at a stock solution of 20 mg/ml. Serial dilutions were prepared to final concentrations ranging from 3.12-400 µg/ml, to screen for activity, and further incubated for 72 h. Controls included vehicle treated cells (2% DMSO), medium and cells, and a positive control, 'Actinomycin D' with concentrations ranging between 0.002 -0.5 µg/ml. Blank plates were included as above without any cells. After 72 h, XTT (50 µl) was added to a final concentration of 0.3 mg/ml and the plates were further incubated for 2 h. The absorbance was read at 490 nm and 690 nm (reference wavelength) using a BIO-TEK Power-Wave XS multiwell plate reader (A.D.P, Weltevreden Park, South Africa). The assay was performed in triplicate to calculate a range in which the fifty percent inhibitory concentration (IC50) could be determined. Antimicrobial activity against P. acnes The antimicrobial activity was performed according to Eloff (1998) , with slight modifications 9 . P. acnes were maintained on sterile nutrient agar plates and sub-cultured. Subcultures of 72 h were inoculated in nutrient broth and treated to determine the minimum inhibitory concentration (MIC). Extracts were dissolved in 10% DMSO. In 96-well plates, 100 µl of each extract was serially diluted 2-fold (in triplicate) with concentration ranging from 3.9 -500 µg/ml. P. acnes subcultures were inoculated in sterile nutrient broth and prepared to a density of 1.5 x 10 8 colony forming units (CFU) per ml (CFU/ml) corresponding with the 0.5 McFarland Standard. Inoculated nutrient broth (100 µl) was added to the plates. Tetracycline (0.2 mg/ml), at a concentration ranging from 0.781 -100 µg/ml, and 10% DMSO were used as the positive and negative controls, respectively. After 72 h incubation at 37°C in anaerobic jars (containing anaerocult A), 20 µl of PrestoBlue was added as the indicator of bacterial growth. The MIC was assessed 1 h after the addition of the growth indicators, as the lowest concentration that inhibited bacterial growth. Antimycobacterial activity M. smegmatis is a fast growing and non-pathogenic species of mycobacterium. It is most commonly used as a model in the physiology of mycobacteria, as it has relevance to the pathogenic species M. tuberculosis 10 . M. tuberculosis (H37Rv) M. tuberculosis was prepared two weeks before the commencement of the MABA assay. The bacterium was sub-cultured and incubated at 37ºC using Middlebrook 7H9 broth that was supplemented with glycerol, PANTA and OADC enrichment for 21 days. The inoculum was prepared in sterile 7H9 medium adjusted to a 0.5 McFarland standard (1.5 x 10 8 CFU/ml). This concentration was further diluted to 1:20 ratio and used throughout the experiment. The MIC of the extracts was determined according to the method of Franzblau et al., (1998) with slight modifications 11 . The ethanol extracts were dissolved in 20% DMSO in sterile Middlebrook 7H9 media to obtain a stock solution of 200 mg/ml. A 2-fold serial dilution of each extract was made with the 7H9 medium to yield volumes of 100 µl/well and final concentrations ranging from 3.13 -1000 µg/ml. Isoniazid (INH), at final concentrations ranging from 0.03 -4.0 µg/ml served as the positive control. The inoculum (100 µl) was added to each well to make up the final volume of 200 µl. Control wells, without the tested extracts, and a 5% h at 37ºC. The bacteria were sub-cultured and incubated for a further 24 h at 37ºC or until an optical density (OD600) of 0.1 was obtained. Stock concentrations of the extracts were prepared in 20% DMSO at 4000 µg/ml and Ciprofloxacin was prepared in sterile distilled water at 20 µg/ml. One hundred microliters of the extracts and controls were added to the top wells of a 96-well plate, in triplicate. Controls included 5% DMSO, Ciprofloxacin, media only and bacteria only. Serial dilutions were prepared to final concentrations ranging from 7.8 -1000 µg/ml and 0.04 -5 µg/ml for the extracts and Ciprofloxacin respectively. One hundred microliters of the prepared M. smegmatis culture was added to each well containing the diluted samples to obtain a final volume of 200 µl. The plates were incubated at 37°C for 24 h. After incubation, 50 µl of 1:1 Alamar Blue: 10% Tween 80 was added to the wells. The plates were incubated for a further 24 h at 37°C, and the colour change was recorded.
Solanum tomentosum
Having observed the highest activity for Mundulea sericea against A375 cells, P. acnes, M. tuberculosis and M. smegmatis it was decided to determine the inhibitory activity of the extract on the DPPH free radical, the COX-2 inflammatory enzyme as well as the affinity of the extract for Gtr and Mtr (Table 1 & 2) . Enzyme kinetics on Mycothiol disulfide and Glutathione reductase An adapted method of Hamilton et al., (2009) was used to determine the enzyme inhibition potential of the M. sericea extract on glutathione (Gtr) and mycothiol disulfide (Mtr) reductases 7 . Briefly, the inhibition assay with Mtr and Gtr were carried out at 35ºC in a 96-well plate with 50 mM Hepes (pH 7.6), 0.1 mM EDTA, NADPH (70 µM), Ellman's reagent (DTNB) (100 µM), substrate GSSG and MSSM (60 µM) and varying concentrations of the extract. Stock concentrations of the extract were dissolved in DMSO at a final concentration of 10 mg/ml. The final assay volume was 200 µl. Mtr and Gtr were pre-incubated with NADPH for 5 min at 30ºC before initiating the reaction by the addition of the substrate. Enzyme activity was monitored by means of the increase in absorbance at 405 nm due to TNB formation. The kinetic read intervals were set to capture data every 15 s and the assay was left to run for 15 min at a set temperature of 35⁰C. Initial rates were measured from the linear region of the progress curve. The percentage inhibition was calculated according to the 100% activity where no inhibitor was present.
DPPH scavenging activity
The method of Berrington and Lall (2012) was followed to determine the radical scavenging capacity (RSC) of the extract 8 . Stock solutions of Vitamin C and the M. sericea extract were prepared at 2 mg/ml and 10 mg/ml respectively. To each well in the top row of a 96-well plate, 200 µl of distilled water was added. To the rest of the wells, 110 µl of distilled water was added as a medium. Twenty microliters of extract was added to the first top wells, in triplicate, followed by serial dilution. Final concentrations of the extract and Vitamin C ranged from 3.9 -500 µg/ml and 0.781 -100 µg/ml respectively. Ethanol was used as the blank control. Lastly, 90 µl of 40 mM 2, 2-diphenyl-1-picrylhydrazyl radical (DPPH) ethanolic solution was added to each well, except for the negative control wells where distilled water was added. The plate was left to develop, covered in aluminium foil for 30 min. Absorbencies were determined using a BIO-TEK PowerWave XS multi-plate reader at a wavelength of 515 nm, using KC junior software.
Cyclooxygenase-2 assay
The assay was performed as described by Reininger and Bauer (2006) using human recombinant COX-2
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. COX-2 (0.5 units/ reaction) was added to 180 µl of 100 mM TRIS buffer (pH 8.0), 5 µM porcine hematin, 18 mM Lepinephrine, and 50 µM Na2EDTA in a 96-well plate. Stock concentrations of the extracts were prepared at 10 mg/ml in DMSO. Ten microlitres of the extracts were added to the wells at a final concentration of 10 µg/ml. Ibuprofen was used as the positive control and tested at final concentrations of 10 µM (stock concentration), 2 µM and 0.4 µM. DMSO at 5 % was used as the vehicle control. The reaction was initiated after 5 min incubation at room temperature by adding 5 µl of 10 µM arachidonic acid to all the wells and incubated for a further 20 min. Lastly, 10 µl of 10% formic acid was added to stop the reaction. The amount of PGE2 produced was measured using the PGE2 ELISA kit after the dilution of samples in a ratio of 1:15. The absorbance was read at 405 nm using a BIO-TEK Power-Wave XS multi-well plate reader. The results were expressed as percentage inhibition of PGE2 synthesis in comparison with the blank. The IC50 values were calculated from four different concentrations using Microsoft Excel.
Molecular docking of COX-2
Molecular docking was performed using the molecular docking program GOLD 13 . It uses a genetic algorithm which considers ligand conformational flexibility along with partial protein flexibility i.e. side chain residues. The default docking parameters were employed for the docking study. It includes 100,000 genetic operations on a population size of 100 individuals and mutation rate of 95 as used by various recent studies [14] [15] [16] . The crystal structure of COX-2 from Homo sapiens was taken from the Protein Data Bank (PDB ID: 5IKR) 17 . It has a crystal structure resolution of 2.34Å and contained an inhibitor; mefenamic acid in the active site. The structures of the compounds used for docking into the COX-2 crystal structure were sketched using Chemdraw3D and minimized considering RMSD cut-off of 0.1Å. The docking protocol was set by extracting and re-docking mefenamic acid in the COX-2 crystal structure with RMSD ≤ 0.68Å. It was followed by docking of all compounds including the known inhibitor, mefenamic acid, into the active site defined as 6Å regions around the co-crystal ligand in the COX-2 enzyme. Further, all docked compounds were evaluated for possible molecular interactions with COX-2 active site residues using PyMol Molecular Graphics System 18 .
Statistical analysis
The presented data is expressed as the mean ± SD (n=3). Statistical analysis was done using one-way analysis of variance (ANOVA) using the GraphPad Prism statistical software. An ANOVA with post Tukey's comparison was used for the Gtr and Mtr assay with difference p<0.001 as statistically significant.
RESULTS AND DISCUSSION

Plant collection
In the present study, 74 plant extracts (total of 33 families) were prepared to determine their anticancer and antimicrobial activities. Some extracts were prepared from the same plant species, however, a different plant part was extracted. The majority of plant species collected form part of the Fabaceae family (19%). Thereafter, Combretaceae (5.4%), Euphorbiaceae (5.4%), Acanthaceae (5.4%), and Asteraceae (4.1%) together form a total of 39.3%. The remaining 60.7% belong to 28 families, with the majority represented by one plant species; however, there are some that are also represented by two species (Table 1) . This indicates that traditionally the Fabaceae family forms the majority of plants that are used for medicinal purposes (Table 1) . Plant extracts were prepared from 11 different plant parts; of which the majority was prepared from roots (28%), followed by leaves (23%) and stems (18%). The root bark and bulbs each contributed towards 6.3%, followed by aerial parts, seeds, and the whole plant, each contributing 3.6%. Lastly, flowers and bark each made up 2.7% and fruit extracted the least with only 1.8%.
Cytotoxicity on A375 cells
All the extracts were tested for their anticancer activity against human melanoma cells (A375). The only extract which showed potential against the selected cell line was the ethanolic root extract of M. sericea, which belongs to the Fabaceae family, with an IC50 value ranging between 50 and 100 µg/ml. This was compared to the positive control, Actinomycin D with an IC50 value of 3.5 x 10 -2 ± 0.001 µg/ml. The cytotoxicity of M. sericea is not well documented however, there are many reports on the cytotoxicity of Mundulea chapelieri. In a previous study by Cao et al., (2004), 11 compounds were isolated from the methanolic extract of M. chapelieri, namely: isomundulinol, 3-deoxy-MS-II, 8-(3, 3-dimethylallyl)-5, 7-dimethoxyflavanone, MS-II, mudulinol, mundulone, munetone, rotenolone, rotenone, tephrosin, and 8-alphaacetoxyelemol. The isolated compounds were then tested on human ovarian cancer cells (A2780) and rotenolone and rotenone were found to be the most active with IC50 values of 0.5 and 0.7 µg/ml respectively. In a study by Mazimba et al., (2012) similar compounds were isolated from the leaves, stem bark and twigs of M. sericea 19 . This included 11 known compounds and 1 new compound. Compounds present included; mundulea lactone, mundulin, lupinifolin, MS-II, mundulinol, lupinifolinol.
5-methoxylupinifolinol, sericetin, hexacosanyl tetracosanoate, α-stigmasterol, lupeol and a new compound 5-methoxymundulin. There are reports on the anticancer activity of a compound present in M. sericea, known as deguelin. It has been reported to significantly inhibit the proliferation of various breast cancer cell lines, lung cancer and prostate cancer [20] [21] [22] .
Antibacterial activity against P. acnes
The most predominant plant family used in this study was the Fabaceae family with a total number of 14 species. It was not surprising that most of the active species against P. acnes came from this plant family as they are used in the treatment of a number skin disorders, including wound healing, infectious diseases, sores or ulcers, skin irritation, burns and inflammatory skin conditions 23 . Dalbergia melanoxylon and M. sericea showed the lowest MICs against P. acnes (Table 1 ). An ethanolic extract of D. melanoxylon previously showed antimicrobial activity against Staphylococcus aureus, a Gram-positive microorganism known to cause skin disorders, with an MIC of 49 µg/ml 24 . The non-polar extracts of M. sericea have also been tested against S. aureus where the bark showed an MIC of 10 µg/ml while both the twigs and leaves showed an MIC of 50 µg/ml 19 . In the present study, the roots of Dichrostachys cinerea had an MIC of 125 µg/ml and showed better activity compared to the leaves and pods with an MIC of 500 µg/ml against P. acnes in a study conducted by Sharma and Lall, (2014) 25 . Acacia karroo inhibited P. acnes at a concentration of 125 µg/ml. This species also showed an MIC of 125 µg/ml when extracted with acetone 26 . Chamaecrista capensis had an MIC of 62.5 µg/ml in the present study, and is reported for the first time for its antibacterial activity against P. acnes. The other prominent plants investigated belonged to the Combretaceae and Euphorbiaceae families. There were no active extracts from the Euphorbiaceae, however, Combretum apiculatum and Combretum imberbe from the Combretaceae family showed MICs of 125 µg/ml and 31.25 µg/ml, respectively against P. acnes. These results were confirmed by a study performed by Sharma and Lall (2014) where the MIC of C. apiculatum against P. acnes strain 11827 was also found to be 125 µg/ml 25 . There have been many reports on the antibacterial activity of C. imberbe against other bacteria by previous researchers. The antimicrobial activity of the dichloromethane (DCM) leaf extract of C. imberbe showed an MIC of 39 µg/ml against S. aureus. The DCM extract was then fractionated to obtain a chloroform partition which showed an MIC of 10 µg/ml. From this partition, 5 oleanene-type triterpenoids were obtained. These included 1, 3-Dihydroxy-12-oleanen-29-oic, 1-Hydroxy-12-olean-30-oic acid, 3, 30-Dihydroxyl-12-oleanen-22-one, 1, 3, 24-Trihydroxyl-12-olean-29-oic acid and 1, 23-Dihydroxy-12-oleanen-29-oic-acid-3-O-2,4-di-acetyl-lrhamnopyranoside which showed MICs at 125, 94, 125, 63 and 63 µg/ml, respectively 27, 28 . The acetone leaf extract of C. imberbe showed an MIC of 1600 µg/ml and that of C. apiculatum 400 µg/ml against S. aureus. This suggested that increasing the polarity of the extraction solvent might decrease the antimicrobial activity against Gram-positive bacteria as reported earlier 29 . P. acnes was also more susceptible to antibiotics when compared to other Staphylococcus species such as S. epidermidis which have been isolated from acne lesions. This could explain why the MICs against P. acnes in this study are lower than those found in other studies which were tested against S. aureus 30 .
Antimycobacterial activity
The general trend observed for antimycobacterial activity in the present study was that the MIC obtained against M. smegmatis was found to be lower than against M. tuberculosis (Table 1) . This may be due to the differences between the two species of mycobacteria. The Fabaceae and Combretaceae families showed the most promising activity against both the species of mycobacteria. Fabaceae/ Leguminosae are the second biggest plant family and regarded as one of the most important due to its edibility and medicinal properties. Many plant extracts investigated within this family showed significant inhibition of both M. smegmatis and M. tuberculosis. M. sericea showed the highest inhibition against both M. tuberculosis and M. smegmatis with MIC values of 125 µg/ml and 31.25 µg/ml respectively. Crotalaria agatiflora and Indigofera arrecta also showed promising results with MIC values of 250 and 500 µg/ml against M. smegmatis and M. tuberculosis respectively. Many of the phytochemicals responsible for antimycobacterial activity are flavonoids, saponins and tannins 31, 32 . Scrophulariaceae has a family name that can be traced back to the word scrofula, a tuberculosis infection of the lymph nodes in the neck. Many plants in this family are known to be antiviral, anti-inflammatory, antifungal and antimicrobial. Phytochemical analysis showed iridoids and saponins as the main constituents responsible for its medicinal properties 32 . Although only moderate activity was found for Asparagus buchananii against M. tuberculosis with an MIC of 500 µg/ml, Asparagaceae contains alkaloids known for their antimicrobial properties 33 . Blepharis subvolubilis subsp. subvolubilis from the Acanthaceae family showed an MIC of 250 µg/ml against M. smegmatis. Three out of the four plant extracts tested from the Combretaceae family showed antimycobacterial activity against both mycobacteria. C. imberbe showed the lowest MIC values against both M. smegmatis and M. tuberculosis with MIC values of 250 µg/ml and 125 µg/ml respectively. Combretaceae is known for its antibacterial properties and many species of this family have been used traditionally for treating individuals infected with tuberculosis 34 . Numerous compounds known for their antimicrobial properties have been isolated from this family. Many plant species found in the Commelinaceae family have been reported for their antioxidant and antibacterial properties. Commelina benghalensis showed activity against M. tuberculosis with an MIC of 250 µg/ml. A known active compound against mycobacteria found in the Ebenaceae family is 7-methyljuglone (7-Mj) 35 . This compound is found in both the Diospyros and Euclea genus as well as in Diospyros lycioides, which may be the reason for the MIC values of 500 µg/ml and 250 µg/ml found against M. smegmatis and M. tuberculosis, respectively 36 . Asteraceae, Verbenaceae, Cactaceae, Apocynaceae, Solanaceae, Compositae and Rhamnaceae all have moderate activity against M. tuberculosis with MIC values of between 250 and 500 µg/ml. Oleaceae and Sapindaceae also had moderate activity against M. smegmatis with MIC values of 500 µg/ml and high MIC values of 1000 µg/ml. Sphedamnocarpus pruriens subsp.
pruriens showed high activity against M. tuberculosis with an MIC value of 125 µg/ml. No previous results were found for activity against any mycobacteria species.
Enzyme inhibition on Mycothiol disulfide and Glutathione reductase
Most living organisms contain a thiol group, and a functional homolog of Glutathione has been identified from M. tuberculosis. This low molecular weight thiol producing enzyme was named mycothiol disulfide reductase (Mtr) 37 . The enzyme catalyzes the reduction of mycothiol disulfide to mycothiol (MSH) 38 . Like its glutathione human analogue, MSH plays a crucial role in protection from oxidative stress within the bacteria and is vital for the survival of the bacteria 39 . Bacteria deficient in producing MSH have shown increased sensitivity to oxidative stress, highlighting the importance of this process Mtr as a possible drug target 40 . Inhibition assays of M. sericea on human glutathione (Gtr) and mycobacterial mycothiol disulfide reductase (Mtr) were evaluated. The extract of M. sericea showed no inhibition on Gtr at a concentration range of 15.62 -1000 µg/ml (Fig.1a) . The activity on Mtr was more substantial with inhibition occurring at 62.5 and 125 µg/ml (Fig.1b ). An increase in activity could be observed at 1000 µg/ml, this might be explained by solvent saturation and microprecipitation of the dissolved compounds. A slight precipitation could be observed at the highest concentration, which will have an effect on the scattering of light due to the turbidity Antioxidant activity of Mundulea sericea The ethanolic stem extract of M. sericea in the present study showed a dose-dependent inhibitory effect on the DPPH free radical which was compared to that of the positive control Vitamin C with an IC50 of 60.52 ± 2.40 µg/ml ( Table 2 ). The antioxidant activity of M. sericea is not well explored as no previous reports were found on its activity. There are however, reports that detected the presence of flavonoids and terpenoids in both the leaves and shoots of M. sericea, which explains the marginal antioxidant activity as observed in the present study 41 . Table 2 : Anti-inflammatory and antioxidant and activity of M. sericea Anti-inflammatory activity of Mundulea sericea The anti-inflammatory activity of the M. sericea extract was determined by using the COX-2 enzyme. The extract was able to inhibit the COX-2 enzyme, which was comparable to that of the positive control, Ibuprofen (Table 2 ). In a previous study by Lee et al., (2004) , the rotenoid, deguelin, which has previously been isolated from M. sericea was able to inhibit COX-2 protein expression in squamous human bronchial epithelia cells (HBE) 42 .
Molecular docking of COX-2
The molecular docking study was performed to determine the binding mode of compounds isolated from M. sericea in the COX-2 active site. The compounds previously described by Mazimba et al., (2012) and Bester and Grobler (2008) were used for docking purposes (Table 3) 19,43 . Previous molecular docking studies have been performed using the COX-2 crystal structures (PDB ID: 3NT1, 1PXX) from Mus musculus [44] [45] [46] [47] . In these studies, active site residues Ser353, Tyr355, Tyr385, Arg513, Met522, and Ser530 were reported to be involved in the H-bond interactions with docked compounds. However, H-bond interactions with residues Tyr355, Tyr385 and Ser530 were reported to be key interactions for COX-2 inhibition. In the present study, the COX-2 crystal structure (PDB ID: 5IKR) from Homo sapiens were used for the docking study. It has an 88% amino acid sequence identity with the COX-2 enzyme from Mus musculus (Fig.3) . Furthermore, a fitness score termed as Gold docking score was used to rank the various docked poses of the compounds. The docking scores were derived using the geometrical properties and bonding affinities of the ligand. All compounds were docked in the active site of COX-2 successfully. The mefenamic acid inhibitor was present as a co-crystal ligand in the 5IKR structure. It was docked into the active site of COX-2 showing very little deviation from the cocrystal ligand (RMSD ≤ 0.68Å). In addition, similar to previous reports, re-docked mefenamic acid also showed key H-bond interactions with active site residues Tyr385 and Ser530 for COX-2 inhibition (Fig 4) . Among the docked compounds, lupinifolinol and mundulin showed high docking scores of 50.3 and 53.09 respectively and formed H-bond interactions with the active site residues. In contrast lupinifolin, mundulea lactone and mundulinol did not show any H-bond interactions with the active site residues therefore, the docking scores were lower compared to lupinifolinol and mundulin. Lupeol, having a five fused ring, did not dock into the active site whereas tephrosin, with a five fused ring system, showed a docking score of 46.20. It showed that fused saturated rings produced conformational restriction on lupeol, however, the three unsaturated rings in tephrosin provided sufficient planarity to allow accommodation in the active site. The rest of the compounds showed reasonable docking scores and interactions with the key residues along with some additional residues in the cavity. The observation can be concluded as cumulative interactions of these compounds may be responsible for COX-2 inhibitory activity of M. sericea. CONCLUSION M. sericea was able to inhibit the growth of A375 cells, as well as the two species of mycobacteria and P. acnes. These results show the broad spectrum activity of the ethanolic extract of M. sericea. The extract also showed potential as an anti-inflammatory and its affinity for Mtr as a target for the inhibition of M. tuberculosis. Furthermore, based on molecular docking studies, lupinifolinol and mundulin showed the highest fit for the COX-2 enzyme when compared to mefenamic acid. These two compounds could potentially explain the anti-inflammatory activity of M. sericea.
